These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5451221)

  • 21. Surgical resection and limited chemotherapy for abdominal undifferentiated lymphomas.
    Janus C; Edwards BK; Sariban E; Magrath IT
    Cancer Treat Rep; 1984 Apr; 68(4):599-605. PubMed ID: 6713416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of bone marrow toxicity of high-dose cyclophosphamide associated with inefficient drug metabolism.
    Zucchetti M; Zambetti M; Hartley JM; D'Incalci M
    Ann Oncol; 1993 Dec; 4(10):895. PubMed ID: 8117611
    [No Abstract]   [Full Text] [Related]  

  • 23. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J; Murphy AV; Arneil GC
    Lancet; 1974 Oct; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Bodey GP; Rodriguez V; Hart J; Freireich EJ
    Cancer Chemother Rep; 1970 Aug; 54(4):255-62. PubMed ID: 4946010
    [No Abstract]   [Full Text] [Related]  

  • 26. [Attempt at treatment of acute leukemias with cytosine-arabinoside according to Skipper's method].
    Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C
    Nouv Rev Fr Hematol; 1969; 9(2):199-204. PubMed ID: 4239783
    [No Abstract]   [Full Text] [Related]  

  • 27. Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas, and other neoplasms.
    Stolinsky DC; Bogdon DL; Pugh RP; Braunwald J; Hestorff R; Bateman JR
    Cancer Chemother Rep; 1973; 57(4):481-4. PubMed ID: 4586955
    [No Abstract]   [Full Text] [Related]  

  • 28. Adverse events during the Scleroderma Lung Study.
    Furst DE; Tseng CH; Clements PJ; Strange C; Tashkin DP; Roth MD; Khanna D; Li N; Elashoff R; Schraufnagel DE;
    Am J Med; 2011 May; 124(5):459-67. PubMed ID: 21531236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity.
    DeWys WD; Goldin A; Man ; El N
    Cancer Res; 1970 Jun; 30(6):1692-7. PubMed ID: 5457936
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperkalaemia, a sequel to chemotherapy of Burkitt's lymphoma.
    Arseneau JC; Bagley CM; Anderson T; Canellos GP
    Lancet; 1973 Jan; 1(7793):10-4. PubMed ID: 4118535
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preliminary therapeutic results of treatment of non-Hodgkin lymphoma in children according to the BACOP program].
    Bogusławska-Jaworska J; Grześkowiak-Melanowska J; Kaczmarek M; Kościelniak E; Legutko L; Sońta-Jakimczyk D; Sroczyńska M; Wojcik Z
    Pediatr Pol; 1980 Feb; 55(2):207-10. PubMed ID: 6154919
    [No Abstract]   [Full Text] [Related]  

  • 32. Host defences to Burkitt tumour.
    Ngu VA
    Br Med J; 1967 Feb; 1(5536):345-7. PubMed ID: 6017492
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclophosphamide, vincristine and sequential split-course radiotherapy in the treatment of small cell lung cancer.
    Holoye PY; Samuels ML
    Chest; 1975 Jun; 67(6):675-9. PubMed ID: 165045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amelioration of the side effects of cyclophosphamide.
    Hussey JL; Kisken WA
    Surg Forum; 1970; 21():109-11. PubMed ID: 4328377
    [No Abstract]   [Full Text] [Related]  

  • 35. Burkitt's lymphoma in Ibadan: hematologic response to single, large, intravenous dose of cyclophosphamide. Case reports.
    Durodola JI
    J Natl Med Assoc; 1976 May; 68(3):185-7. PubMed ID: 933184
    [No Abstract]   [Full Text] [Related]  

  • 36. Endemic Burkitt lymphoma of maxillofacial region: results of induction treatment with cyclophosphamide plus methotrexate in West Africa.
    Béogo R; Nacro B; Ouédraogo D; Ouoba K
    Pediatr Blood Cancer; 2011 Jul; 56(7):1068-70. PubMed ID: 21344617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term remissions following one and two-dose chemotherapy for African lymphoma.
    Burkitt D
    Cancer; 1967 May; 20(5):756-9. PubMed ID: 6024288
    [No Abstract]   [Full Text] [Related]  

  • 38. Survival of Burkitt's lymphoma patients in Mulago Hospital, Uganda.
    Morrow RH; Pike MC; Kisuule A
    Br Med J; 1967 Nov; 4(5575):323-7. PubMed ID: 6053614
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of a high dose cyclophosphamide regimen in childhood tumors.
    Finklestein JZ; Hittle RE; Hammond GD
    Cancer; 1969 May; 23(5):1239-42. PubMed ID: 4305107
    [No Abstract]   [Full Text] [Related]  

  • 40. VP-16-213 in the treatment of stage III and IV diffuse large cell lymphoma.
    Jacobs P; King HS; Dent DM; Hayes M
    Cancer; 1985 Sep; 56(5):1006-13. PubMed ID: 3893681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.